Gut microbiome components predict response to neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): a prospective study.

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42292847

Bin Zhou; Chuying Huang; Hongli Liu; Jianli Hu; Jun Xue; Mengjiao Wu; Min Jin; Qiai You; Ruihan Li; Tao Zhang; Xinyi Chen; Yan Zong; Yilin Xiao; Zhenyu Lin

Jun 16, 2026